Additionally, given the deleterious effect of interferons on immunotherapy by upregulation of PDL-1 on tumor cells and macrophages [32], another relatively obvious strategy would be to co-administer antibodies that block PD1 or PDL-1. This evidence concerns the gene CD274 and neoplasm.